Under the Federal Food, Drug and Cosmetic Act (FD&C Act) of 1938, it is a crime to market unsafe cosmetic products.
What does FD&C stand for?
FD&C stands for Food, Drug and Cosmetic
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of FD&C
- Functional Decomposition
- Functional Dependency
- Functional Description
- Funeral Director
- Winds Aloft forecast
- Field Engineer
- Field Marshall
- Finding, Development and Acquisition Cost
- Functional Description & Allocation
- Facilities Development and Construction
- Food, Drug and Cosmetics (Act of 1938)
- Food, Drug, and Cosmetics Act
- Facilities Design & Construction Center (Coast Guard)
- Freight, Demurrage and Defense (also seen as FDD; shipping industry)
- Fat, Dumb and Happy
- Frequency-Division Additive White Gaussian Noise (electrical engineering)
- Finite Difference Bio-Heat Transfer Equation
- Finite Difference Beam Propagation Method
- Frequency Domain Decision Feedback Equalizer
- Frequency-Domain Electric Field Integral Equation
Samples in periodicals archive:
Cosmetics are regulated under the Food, Drug and Cosmetic Act, which is enforced by the U.
``The court finds that tobacco products fit within the Food, Drug and Cosmetic Act's definition of `drug' and `device,' '' Osteen wrote.
The NDA was filed under Section 505(b)(2) of the Food, Drug and Cosmetic Act.
In addition, DUSA believes that certain actions of The Cosmetic Pharmacy go beyond the activities which are permitted under the Food, Drug and Cosmetic Act, and as a result, it has advised the U.
The injunction had originally been ordered pending final resolution of CollaGenex's challenge to the FDA's decision to classify Periostat(R) as an antibiotic, thereby denying CollaGenex the patent and exclusivity protection otherwise available under the Hatch Waxman amendments to the Food, Drug and Cosmetic Act.
CollaGenex also continues to challenge in the United States District Court for the District of Columbia the decision of the Food and Drug Administration ("FDA") to classify Periostat(R) as an antibiotic, and has sought to compel the FDA to accord CollaGenex patent and exclusivity protection under the Hatch Waxman amendments to the Food, Drug and Cosmetic Act.
Surgin moved to dismiss the complaint on the basis that whether a product has 510(k) clearance or needs a second 510(k) clearance are questions for the FDA to decide under the Federal Food, Drug and Cosmetic Act.